Contamination

Contamination is the presence in a drug sample of material that was not intentionally part of the product — a different psychoactive compound, a residue from synthesis or processing, a heavy metal introduced by equipment, a microbial load, or an inert filler used to extend volume or weight.

It is a property of the supply chain rather than of any drug itself. Unregulated markets carry no quality controls, and there is no requirement that a seller know or disclose what a sample contains. The absence of reported contamination events in a given supply is usually a surveillance gap, not evidence that the supply is clean.

How it is done

Identifying contamination relies on chemical analysis. At the simplest level, colorimetric reagent tests — small kits that produce a colour change in the presence of certain compound classes — can flag the likely presence of an expected substance or suggest something unexpected. Fentanyl test strips, originally designed for urine analysis and adapted for drug checking, detect fentanyl and some of its analogues in a dissolved sample.

Drug checking services offer more rigorous analysis. Methods such as FTIR spectroscopy and gas chromatography–mass spectrometry can identify multiple compounds in a sample and, in some cases, provide rough concentration estimates. These services, where available, represent the most reliable form of pre-use contamination screening.

Physical inspection — checking for unusual colour, texture, or smell — offers only a coarse signal and misses most chemical contamination entirely. Because active compounds are not always evenly distributed throughout a batch or a single pressed tablet, testing one portion of a sample does not guarantee the rest shares the same composition. This uneven distribution is sometimes called a hotspot.

What it cannot tell you

Reagent tests and fentanyl test strips work within specific detection windows. A reagent test indicates the likely presence of a compound class; it does not identify every compound present, measure concentration, or exclude substances outside what it was designed to detect. A strip that returns no fentanyl signal does not establish the absence of fentanyl analogues the strip is not calibrated for, or of entirely different contaminants such as nitazenes, xylazine, or heavy metals.

Even laboratory drug checking has limits. Trace-level contamination may fall below instrument detection thresholds. A sample drawn from one part of a larger batch may not represent the whole. No pre-use method currently in wide use produces a complete chemical inventory of a sample.

The most common wrong conclusion from a reassuring result is that a sample is pure and correctly dosed. A clean reagent reaction and a negative strip result mean only that the methods used did not detect the contaminants they were calibrated for — not that no contaminants are present.